How to reduce the risk of residual shunt during percutaneous treatment of ventricular septal defects. Response
Rev Esp Cardiol (Engl Ed). 2022 Mar;75(3):280.
doi: 10.1016/j.rec.2021.11.018.
Epub 2022 Jan 17.
[Article in
English,
Spanish]
Affiliations
- 1 Unidad de Cardiología Infantil, Hospital Universitario Infanta Leonor, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain. Electronic address: ruth.solana@salud.madrid.org.
- 2 Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Unidad de Cardiología Infantil, Hospital Universitario Gregorio Marañón, Madrid, Spain.
No abstract available
MeSH terms
-
Heart Septal Defects, Ventricular* / surgery
-
Humans
-
Septal Occluder Device*